Before taking efavirenz/emtricitabine/tenofovir, tell your healthcare provider about any medical conditions, allergies, or medications you are taking.
Efavirenz/emtricitabine/tenofovir is a prescription antiretroviral medication used to treat human immunodeficiency virus type 1 (HIV-1) infection. It contains three active ingredients that work together to prevent HIV from multiplying, lower viral load, and help protect your immune system.
Although this medication can effectively control HIV infection, it may cause serious side effects in some people, particularly those with certain pre-existing medical conditions.
Tell your healthcare provider if you have liver disease, kidney disease, osteoporosis, depression, or other significant health concerns before starting treatment.
Your healthcare provider may recommend regular blood tests, medical appointments, and additional monitoring to make sure the medication remains safe and effective.
Lactic Acidosis
In rare cases, evafereniz/emtricitabine/tenofovir may cause a serious condition called lactic acidosis.
Lactic acidosis occurs when too much lactic acid builds up in your bloodstream. This can affect how your organs function and may become life-threatening if not treated promptly.
Emtricitabine and tenofovir disoproxil fumarate, two of the active ingredients in this medication, belong to a group of drugs that have been associated with lactic acidosis.
Possible warning signs include:
- Unusual muscle pain or weakness: You may experience muscle discomfort or weakness without an obvious cause.
- Difficulty breathing: You may feel short of breath or begin breathing faster than normal.
- Severe tiredness: You may feel extremely weak or exhausted, even after resting.
- Dizziness: You may feel lightheaded, faint, or unusually unsteady.
- Stomach pain: You may experience persistent abdominal discomfort.
- Nausea or vomiting: You may feel sick to your stomach or vomit repeatedly.
Lactic acidosis can develop gradually or become serious quickly.
Seek emergency medical attention immediately if you experience severe or unusual symptoms that may indicate lactic acidosis.
Your healthcare provider will determine whether treatment needs to be interrupted and whether additional medical tests are necessary.
Liver Problems
Efavirenz/Emtricitabine/Tenofovir may cause liver problems, including liver inflammation, abnormal liver function tests, and, in rare cases, severe liver damage or liver failure.
Your liver helps process medications and remove harmful substances from your body. If you already have liver disease, your risk of complications may be higher.
Tell your healthcare provider if you have hepatitis B, hepatitis C, cirrhosis, elevated liver enzymes, or another liver condition.
However, serious liver problems have also been reported in people without a previous history of liver disease.
Possible symptoms include:
- Yellowing of your skin or eyes: This may be a sign of jaundice.
- Dark urine: Your urine may become noticeably darker than usual.
- Persistent nausea or vomiting: You may experience ongoing stomach discomfort.
- Severe abdominal pain: You may notice pain or tenderness, especially in the upper right side of your abdomen.
- Unusual tiredness: You may feel significantly weaker or more exhausted than normal.
- Loss of appetite: You may notice a sudden or persistent decrease in your desire to eat.
Your healthcare provider will generally recommend liver function tests before starting treatment and periodically while you are taking the medication.
Efavirenz/emtricitabine/tenofovir is not recommended for people with moderate or severe liver impairment.
Contact your healthcare provider immediately if you notice symptoms of liver problems. Severe symptoms require urgent medical evaluation.
Hepatitis B and Stopping Treatment
If you have both HIV-1 infection and hepatitis B, it is especially important not to stop evairenz/emtricitabine/tenofovir without medical supervision.
Emtricitabine and tenofovir disoproxil fumarate are active against hepatitis B virus as well as HIV.
If these medications are stopped, hepatitis B may become active again or worsen significantly. This is called an acute exacerbation of hepatitis B.
In some cases, a hepatitis B flare-up can cause serious liver damage.
Your healthcare provider should check your hepatitis B status before treatment and may recommend additional monitoring if you have both infections.
If your HIV treatment needs to be changed or discontinued, your healthcare provider will determine how to maintain appropriate hepatitis B treatment.
Do not stop taking efavirenz/emtricitabine/tenofovir on your own. People with HIV and hepatitis B may need close liver monitoring for several months after discontinuation.
Depression and Mood Changes
Efavirenz, one of the active ingredients, may cause mental health side effects in some people.
These effects may include depression, anxiety, unusual mood changes, difficulty sleeping, agitation, or changes in behavior.
More serious psychiatric reactions, including suicidal thoughts and behavior, have also been reported.
The risk may be greater in people with a history of depression or other mental health conditions, although these reactions can also occur in people without a previous diagnosis.
Tell your healthcare provider if you have experienced depression, anxiety, bipolar disorder, suicidal thoughts, or another mental health condition.
Warning signs may include:
- Worsening depression: You may experience increased sadness, hopelessness, or loss of interest in everyday activities.
- Increased anxiety or agitation: You may feel unusually nervous, restless, or irritable.
- Sleep disturbances: You may experience severe insomnia, nightmares, or unusual dreams.
- Unusual thoughts or behavior: You may notice significant changes in how you think, feel, or act.
- Thoughts of self-harm: You may develop new or worsening thoughts about hurting yourself.
Contact your healthcare provider promptly if you experience unusual changes in your mood, thoughts, or behavior.
Family members or caregivers may also help identify concerning changes during treatment.
Seek emergency medical assistance if you feel at immediate risk of harming yourself. In Canada, you can also call or text 988 for suicide crisis support.
Kidney Problems
Tenofovir disoproxil fumarate, one of the active ingredients in efavirenz/emtricitabine/tenofovir, may affect kidney function.
In some people, tenofovir can cause new or worsening kidney problems, including kidney damage that affects the body’s ability to remove waste products and maintain normal mineral levels.
The risk may be higher in people who already have kidney disease, have reduced kidney function, or take other medications that can affect the kidneys.
Tell your healthcare provider if you have a history of kidney disease, abnormal kidney function tests, or other conditions that may affect your kidneys.
Your healthcare provider may recommend blood and urine tests before treatment and periodically afterward.
These tests may include measurements of kidney function, urine protein, and urine glucose.
Contact your healthcare provider if you notice:
- A significant decrease in urination.
- Unusual swelling in your feet, ankles, or legs.
- Persistent muscle weakness.
- Unexplained tiredness.
- New or worsening bone pain.
Because efavirenz/emtricitabine/tenofovir contains fixed doses of three medications, it may not be suitable for people who require individual dose adjustments because of reduced kidney function.
Your healthcare provider may recommend another HIV treatment if your kidney function is significantly impaired.
Bone Loss and Fracture Risk
Long-term use of tenofovir disoproxil fumarate may be associated with reduced bone mineral density.
Bone mineral density refers to the amount of minerals, including calcium, present in your bones. When bone density decreases, bones may become weaker and more likely to fracture.
In some patients, tenofovir may also affect kidney function in ways that interfere with normal bone mineral balance.
Possible bone-related concerns include:
- Reduced Bone Density: Your bones may gradually lose mineral content.
- Osteoporosis: People with osteoporosis may be at increased risk of fractures.
- Bone Pain: Some people may experience persistent or unexplained bone discomfort.
- Increased Fracture Risk: Weakened bones may become more susceptible to fractures, particularly in people with additional risk factors.
Tell your healthcare provider if you have a history of osteoporosis, bone fractures, vitamin D deficiency, or other conditions affecting bone strength.
Your healthcare provider may recommend a bone density test if you have a history of fractures or other significant risk factors for bone loss.
They may also recommend appropriate nutrition, physical activity, and other measures to support bone health.
Contact your healthcare provider if you develop persistent bone pain, muscle weakness, or an unexplained fracture.
Immune Reconstitution Inflammatory Syndrome (IRIS)
When you begin effective HIV treatment, your immune system may gradually become stronger as the amount of HIV in your blood decreases.
In some people, this improvement can trigger an inflammatory response against infections that were already present in the body.
This condition is called immune reconstitution inflammatory syndrome (IRIS).
IRIS can occur when your recovering immune system begins recognizing and responding to infections that previously caused few or no symptoms.
Examples include certain tuberculosis infections, fungal infections, and other opportunistic infections.
Possible symptoms depend on the underlying infection but may include fever, swollen lymph nodes, worsening cough, breathing difficulties, or inflammation in different parts of the body.
IRIS does not necessarily mean your HIV medication is failing. In many cases, it occurs because your immune system is recovering and becoming more active.
Contact your healthcare provider promptly if you develop new or worsening symptoms after starting treatment.
Your healthcare provider will determine whether you need additional tests or medication to manage the underlying infection or inflammation.
Drug Interactions
Efavirenz/emtricitabine/tenofovir can interact with many medications, including prescription drugs, over-the-counter products, vitamins, and herbal supplements.
Some interactions may increase the amount of medication in your bloodstream, raising your risk of side effects.
Other interactions may reduce antiretroviral drug levels, making your HIV treatment less effective and potentially increasing the risk of drug resistance.
Efavirenz affects certain liver enzymes responsible for processing medications. This means it can change how some medicines work in your body.
Examples of medications and products that require particular attention include certain:
- Antifungal medications: Some treatments for fungal infections may interact with efavirenz.
- Seizure medications: Drugs such as carbamazepine, phenytoin, and phenobarbital may affect treatment.
- Tuberculosis medications: Rifampin and related medications may require special consideration.
- Heart rhythm medications: Certain combinations may increase the risk of abnormal heart rhythms.
- Other HIV medications: Some antiretroviral combinations may lead to significant interactions.
- Herbal supplements: St. John’s wort can reduce efavirenz levels and should not be used with this combination.
Certain medications should not be taken with efavirenz/emtricitabine/tenofovir because the interactions can be serious.
Tell your healthcare provider and pharmacist about everything you take, including products that you use only occasionally.
Do not start, stop, or change another medication without checking whether it is safe to use with your HIV treatment.
Cardiovascular Health
People living with HIV may have an increased risk of cardiovascular disease because of several factors, including chronic inflammation, traditional cardiovascular risk factors, and the effects of certain medications.
Some studies have also raised concerns about the possible cardiovascular effects of particular antiretroviral regimens, including some efavirenz-containing treatments.
However, this does not mean that everyone taking evafereniz/emtricitabine/tenofovir will develop heart problems, and the relationship between individual HIV medications and cardiovascular risk can be complex.
Efavirenz may affect cholesterol and triglyceride levels in some patients, making regular monitoring important.
Tell your healthcare provider if you have:
- Heart disease: Including coronary artery disease or a history of heart attack.
- High blood pressure: A condition that increases strain on your heart and blood vessels.
- High cholesterol: Elevated cholesterol or triglyceride levels may increase cardiovascular risk.
- Diabetes: High blood sugar can damage blood vessels over time.
- A history of smoking: Smoking is an important risk factor for heart disease.
Your healthcare provider may recommend monitoring your blood pressure, cholesterol, blood sugar, and other cardiovascular risk factors during treatment.
Maintaining a balanced diet, staying physically active, avoiding smoking, and managing existing medical conditions can also help support heart health.
Do not stop HIV treatment because of concerns about cardiovascular risk. Speak with your healthcare provider about whether your current regimen is appropriate for your individual health needs.
When to Contact Your Healthcare Provider
Contact your healthcare provider if you develop unusual or persistent symptoms while taking Efavirenz/emtricitabine/tenofovir, including worsening depression, persistent nausea, unexplained tiredness, muscle weakness, bone pain, or changes in urination.
You should also seek medical advice if you experience yellowing of your skin or eyes, dark urine, unexplained swelling, or new symptoms after starting HIV treatment.
Seek emergency medical attention immediately if you develop severe breathing difficulties, symptoms of lactic acidosis, a serious allergic reaction, severe psychiatric symptoms, or thoughts of self-harm that place you in immediate danger.
Continue attending regular medical appointments so your healthcare provider can monitor your viral load, kidney function, liver health, and overall response to treatment.
Always take efavirenz/emtricitabine/tenofovir exactly as prescribed. Consistent treatment, regular laboratory monitoring, and early reporting of unusual symptoms can help control HIV infection while reducing the risk of serious complications.
REVIEWS